Phase II trial of bevacizumab in the treatmen...
阅51转0刚刚Phase II study of fulvestrant in recurrent/me...
阅37转0刚刚A phase II study of gemcitabine (gemzar, LY18...
阅52转0刚刚Antiangiogenic therapies in epithelial ovaria...
阅46转0刚刚Effects of bevacizumab and pegylated liposoma...
阅50转0刚刚Management strategies for recurrent platinum
阅53转0刚刚Angiogenesis and molecular markers in advance...
阅32转0刚刚Insulin-like growth factor
阅66转0刚刚An update on the management of uterine c... [...
阅29转0刚刚Anti-Sp17monoclonal antibody
阅40转0刚刚Incorporation of bevacizumab in the primary t...
阅34转0刚刚
-
设计心理学2:与复杂共处
加载中...